Skip to main content

Horstmeier Paul's Form 4 filing

Health Catalyst, Inc. (HCAT) · filed Sep 8, 2021

Accession no.
0001562180-21-005875
Filed
Sep 8, 2021
Trade date
Sep 7, 2021
Filing delay
1 day
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $472.0K. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Horstmeier PaulCIK 0001780978Officer (Chief Operating Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 7, 2021Common StockMOption exerciseAcquired+6,063$15.84+$96,037.92117,039Direct
Sep 7, 2021Common StockSSaleDisposed−6,063$54.89F2−$332,798.07110,976Direct
Sep 7, 2021Common StockSSaleDisposed−2,535$54.91F3−$139,196.85108,441Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Sep 7, 2021Common StockMOption exerciseDisposed−6,063$0.00$068,841Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $54.70 to $55.39, inclusive.

Referenced by the price of 1 transaction in Table I.

F3

Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $54.77 to $55.19, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (2) and (3).

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)